For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $21.50 in the prior trading day, Dianthus Therapeutics Inc (NASDAQ: DNTH) closed at $21.80, up 1.40%. In other words, the price has increased by $1.40 from its previous closing price. On the day, 0.11 million shares were traded. DNTH stock price reached its highest trading level at $22.05 during the session, while it also had its lowest trading level at $21.2327.
Ratios:
Our goal is to gain a better understanding of DNTH by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.30 and its Current Ratio is at 18.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 03, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $48.
On July 26, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $58.Robert W. Baird initiated its Outperform rating on July 26, 2024, with a $58 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNTH now has a Market Capitalization of 645214592 and an Enterprise Value of 364401824. For the stock, the TTM Price-to-Sale (P/S) ratio is 120.15 while its Price-to-Book (P/B) ratio in mrq is 1.89. Its current Enterprise Value per Revenue stands at 67.909 whereas that against EBITDA is -4.4.
Stock Price History:
Over the past 52 weeks, DNTH has reached a high of $33.77, while it has fallen to a 52-week low of $10.22. The 50-Day Moving Average of the stock is -13.35%, while the 200-Day Moving Average is calculated to be -16.24%.
Shares Statistics:
The stock has traded on average 250.81K shares per day over the past 3-months and 203190 shares per day over the last 10 days, according to various share statistics. A total of 29.37M shares are outstanding, with a floating share count of 19.23M. Insiders hold about 35.03% of the company’s shares, while institutions hold 84.90% stake in the company. Shares short for DNTH as of 1734048000 were 5661839 with a Short Ratio of 22.57, compared to 1731628800 on 5442599. Therefore, it implies a Short% of Shares Outstanding of 5661839 and a Short% of Float of 26.840000000000003.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. The consensus estimate for the next quarter is -$0.83, with high estimates of -$0.83 and low estimates of -$0.83.
Analysts are recommending an EPS of between -$2.27 and -$2.27 for the fiscal current year, implying an average EPS of -$2.27. EPS for the following year is -$3.29, with 1.0 analysts recommending between -$3.29 and -$3.29.
Revenue Estimates
A total of 11 analysts have provided revenue estimates for DNTH’s current fiscal year. The highest revenue estimate was $7.08M, while the lowest revenue estimate was $2.7M, resulting in an average revenue estimate of $5.41M. In the same quarter a year ago, actual revenue was $2.83M
